Brief: Astellas Pharma Inc - Notice Regarding Impairment Loss And Extraordinary Losses In Non-Consolidated Financial Results(J-GAAP)
27/04/2026 07:40
April 27 (Reuters) - Astellas Pharma Inc 4503.T: ASTELLAS PHARMA INC - NOTICE REGARDING IMPAIRMENT LOSS AND EXTRAORDINARY LOSSES IN NON-CONSOLIDATED FINANCIAL RESULTS(J-GAAP) Source text: ID:nTSpa7cedf Further company coverage: 4503.T
Recent news on Astellas Pharma
See all newsBrief: Immuneering To Collaborate With Astellas On Clinical Studies Of Investigational CLDN18.2 Programs In Combination With Atebimetinib For Pancreatic Cancer Patients
Health Rounds: New blood test finds early risk for ovarian cancer
Health Rounds: New blood test finds early risk for ovarian cancer
Refile: Astellas employee imprisoned in China to be released in December, Japanese media report
Table: Astellas Pharma -6-MTH group results (IFRS)